MNDBX
Price
$15.75
Change
-$0.02 (-0.13%)
Updated
Sep 3 closing price
Net Assets
2.08B
VEXRX
Price
$110.35
Change
-$0.11 (-0.10%)
Updated
Sep 3 closing price
Net Assets
19.88B
Interact to see
Advertisement

MNDBX vs VEXRX

Header iconMNDBX vs VEXRX Comparison
Open Charts MNDBX vs VEXRXBanner chart's image
MFS New Discovery B
Price$15.75
Change-$0.02 (-0.13%)
VolumeN/A
Net Assets2.08B
Vanguard Explorer Adm
Price$110.35
Change-$0.11 (-0.10%)
VolumeN/A
Net Assets19.88B
MNDBX vs VEXRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MNDBX vs. VEXRX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNDBX is a Hold and VEXRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 19.9B vs. MNDBX (2.08B). VEXRX pays higher dividends than MNDBX: VEXRX (0.50) vs MNDBX (0.00). MNDBX was incepted earlier than VEXRX: MNDBX (28 years) vs VEXRX (24 years). MNDBX (2.04) is less costly to investors than VEXRX (0.33). MNDBX is a more actively managed with annual turnover of: 56.00 vs. VEXRX (35.00). MNDBX has a lower initial minimum investment than VEXRX: MNDBX (1000) vs VEXRX (50000). MNDBX annual gain was more profitable for investors over the last year : 8.38 vs. VEXRX (0.82). VEXRX return over 5 years is better than : 10.65 vs. MNDBX (-30.47).
MNDBXVEXRXMNDBX / VEXRX
Total Expense Ratio1.960.33594%
Annual Report Gross Expense Ratio2.040.33618%
Fund Existence28 years24 years-
Gain YTD6.1953.379183%
Front LoadN/AN/A-
Min. Initial Investment1000500002%
Min. Initial Investment IRAN/AN/A-
Net Assets2.08B19.9B10%
Annual Yield % from dividends0.000.50-
Returns for 1 year8.380.821,021%
Returns for 3 years23.7819.87120%
Returns for 5 years-30.4710.65-286%
Returns for 10 years-20.0732.65-61%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VALIX14.380.06
+0.42%
Value Line Capital Appreciation Investor
FCDCX32.26N/A
N/A
Fidelity Advisor Stock Selector Sm Cp C
ITRGX68.71N/A
N/A
VY® T. Rowe Price Growth Equity S2
ABRWX18.30N/A
N/A
DSS AmericaFirstMonthlyRisk-OnRisk-Off I
ICRPX25.36N/A
N/A
VY® CBRE Real Estate A